美国 · SEC FORM 4
Conexeu Sciences Inc.
CXNU · Nasdaq · CIK 0002066836 · Healthcare
内部人信号
2 位买方 · 2 条买入交易行 · $676.0K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
买方广度与集中度
Roles in the peak window: Director,TenPercentOwner, TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
信号历史
最新留档分数
- 54.8
- 54.7
- 54.7
- 54.6
- 54.7
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景 capture is under review for CXNU. Last attempt: 2026-10-11T13:56:40.608816+00:00. —
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-18 | Purcell Lynn Sebastian | 买入 (P) | Common Stock | 202,500 | USD 0.80 | USD 162,000 | SEC 申报 ↗ |
| 2026-05-12 | Purcell Lynn Sebastian | 买入 (P) | Common Stock | 422,500 | USD 0.80 | USD 338,000 | SEC 申报 ↗ |
| 2026-05-12 | OnePointTwo Capital Ventures LLC | 买入 (P) | Common Stock | 422,500 | USD 0.80 | USD 338,000 | SEC 申报 ↗ |
Form 4 申报证据
11 transaction lines in the latest 365-day window; 11 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Bogart David Robert | 期权行权／转换 (M) | Common Stock | 750,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Sharpe Jeffrey Nathan | 期权行权／转换 (M) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-04 | Purcell Lynn Sebastian | X (X) | Common Stock | 217,608 | USD 2.30 | USD 500,498 | SEC 申报 ↗ |
展开近期 Form 4 证据 (11 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-25 | Bogart David Robert | 期权行权／转换 (M) | Common Stock | 750,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-14 | Sharpe Jeffrey Nathan | 期权行权／转换 (M) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-09-04 | Purcell Lynn Sebastian | X (X) | Common Stock | 217,608 | USD 2.30 | USD 500,498 | SEC 申报 ↗ |
| 2026-09-04 | Purcell Lynn Sebastian | X (X) | Common Stock | 217,608 | USD 2.30 | USD 500,498 | SEC 申报 ↗ |
| 2026-06-18 | Purcell Lynn Sebastian | 买入 (P) | Common Stock | 202,500 | USD 0.80 | USD 162,000 | SEC 申报 ↗ |
| 2026-06-18 | Wright Michael G. | 期权行权／转换 (M) | Common Stock | 250,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-26 | Wright Michael G. | 期权行权／转换 (M) | Common Stock | 400,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-22 | Sharpe Jeffrey Nathan | 期权行权／转换 (M) | Common Stock | 500,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-14 | Lorenc Zbigniew Paul | 奖励／授予 (A) | Common Stock | 11,175 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-12 | Purcell Lynn Sebastian | 买入 (P) | Common Stock | 422,500 | USD 0.80 | USD 338,000 | SEC 申报 ↗ |
| 2026-05-12 | OnePointTwo Capital Ventures LLC | 买入 (P) | Common Stock | 422,500 | USD 0.80 | USD 338,000 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-19 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CXNU |
| CIK | 0002066836 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 11 transaction lines from 2026-05-12 to 2026-09-25 3 P purchase lines · 0 S sale lines · 8 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.